c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration

NCT05882292 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University